Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Pediatric Blood & Cancer
|
April 17, 2024
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group
Jonathan Metts, Wei Xue, Zhengya Gao, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
March 9, 2022
A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors
Jonathan Metts, Brittany Harrington, Emad Salman, et al.
Children (Basel, Switzerland)
|
May 4, 2026
Recent Trends in Clinical Trials for Pediatric Sarcoma in the United States: An Analysis of ClinicalTrials.gov
Khaled Alkhawaldeh, Signe Thorpe, Sukjoo Cho, et al.
Antioxidants (Basel, Switzerland)
|
July 2, 2021
Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia
Zhengqi Wang, Tian Mi, Heath L Bradley, et al.
Journal of Pediatric Hematology/Oncology
|
June 23, 2025
Adolescent and Young Adult Oncology in the United States in 2025: Finding Its Place in the Oncology World-Part 1 of 2
Peter H Shaw, Sharon M Castellino, Jonathan Metts, et al.
JPGN Reports
|
March 28, 2024
Appendiceal mucinous neoplasm in adolescence: Diagnosis, management, and surveillance
Andrew Farrar, Paola Blanco, Abigail Fabbrini, et al.
Scientific Reports
|
July 2, 2017
Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells
Jonathan Metts, Heath L Bradley, Zhengqi Wang, et al.
Cancer
|
March 1, 2023
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group
Jonathan Metts, Wei Xue, Zhengya Gao, et al.
Pediatric Blood & Cancer
|
October 15, 2025
A Phase I Trial of Nab-Paclitaxel in Combination With Gemcitabine for Relapsed/Refractory Pediatric Solid Tumors
Jonathan Metts, Kevin Ginn, Zhulin He, et al.
Journal of Adolescent and Young Adult Oncology
|
April 23, 2026
Development and Pilot Evaluation of REFLECT: A Digital Health Application Supporting Fertility and Genetic Decision-Making in Adolescent and Young Adult Oncology
Sarita Pathak Desai, Lindsay Fuzzell, Paige W Lake, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Pediatric Blood & Cancer
|
April 17, 2024
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group
Jonathan Metts, Wei Xue, Zhengya Gao, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
March 9, 2022
A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors
Jonathan Metts, Brittany Harrington, Emad Salman, et al.
Children (Basel, Switzerland)
|
May 4, 2026
Recent Trends in Clinical Trials for Pediatric Sarcoma in the United States: An Analysis of ClinicalTrials.gov
Khaled Alkhawaldeh, Signe Thorpe, Sukjoo Cho, et al.
Antioxidants (Basel, Switzerland)
|
July 2, 2021
Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia
Zhengqi Wang, Tian Mi, Heath L Bradley, et al.
Journal of Pediatric Hematology/Oncology
|
June 23, 2025
Adolescent and Young Adult Oncology in the United States in 2025: Finding Its Place in the Oncology World-Part 1 of 2
Peter H Shaw, Sharon M Castellino, Jonathan Metts, et al.
JPGN Reports
|
March 28, 2024
Appendiceal mucinous neoplasm in adolescence: Diagnosis, management, and surveillance
Andrew Farrar, Paola Blanco, Abigail Fabbrini, et al.
Scientific Reports
|
July 2, 2017
Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells
Jonathan Metts, Heath L Bradley, Zhengqi Wang, et al.
Cancer
|
March 1, 2023
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group
Jonathan Metts, Wei Xue, Zhengya Gao, et al.
Pediatric Blood & Cancer
|
October 15, 2025
A Phase I Trial of Nab-Paclitaxel in Combination With Gemcitabine for Relapsed/Refractory Pediatric Solid Tumors
Jonathan Metts, Kevin Ginn, Zhulin He, et al.
Journal of Adolescent and Young Adult Oncology
|
April 23, 2026
Development and Pilot Evaluation of REFLECT: A Digital Health Application Supporting Fertility and Genetic Decision-Making in Adolescent and Young Adult Oncology
Sarita Pathak Desai, Lindsay Fuzzell, Paige W Lake, et al.
Page
of 4